Early changes in tumor metabolism after treatment: the effects of stereotactic radiotherapy.
Four patients with intracranial neoplasms, two with malignant gliomas and two with brain metastases, were treated with stereotactic radiotherapy. Patients received between 15 and 27.5 Gray of photon irradiation to the central tumor target point; the 80% isodose line covered the periphery of the tumor as determined by contrast enhanced computed tomography. Patients underwent a sequence of three Positron Emission Tomographic scans using [18F]-fluorodeoxyglucose (PET-FDG)--a baseline scan the day before treatment, and follow-up scans 1 and 7 days after treatment. Ratios between the maximal tumor regional cerebral metabolic rate for glucose (rCMRGlu) (T*) and the contralateral remote white matter rCMRGlu (RW), that is, the glucose uptake ratio (T*/RW), were calculated. The percent change in ratios relative to each patient's baseline scan were calculated. Ratios increased 25% to 42% 1 day post-radiotherapy, then decreased to between 10% above and 12% below the baseline value 7 days post-radiotherapy. The T*/RW increased acutely after stereotactic radiotherapy in a fashion similar to that previously described following chemotherapy with a complex multi-drug regimen. A common metabolic pathway may underlie the increase in T*/RW after these different treatments.
Rozental
J M
JM
Neurology Services, Wm. S. Middleton Memorial Veterans Hospital, Madison, WI 53705.
Levine
R L
RL
Mehta
M P
MP
Kinsella
T J
TJ
Levin
A B
AB
Algan
O
O
Mendoza
M
M
Hanson
J M
JM
Schrader
D A
DA
Nickles
R J
RJ
D001932:Brain Neoplasms / Q000378:metabolism / Q000532:radiotherapy* / Q000556:secondary; D002292:Carcinoma, Renal Cell / Q000378:metabolism / Q000532:radiotherapy / Q000556:secondary; D003847:Deoxyglucose / Q000031:analogs & derivatives; D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D005910:Glioma / Q000000981:diagnostic imaging / Q000378:metabolism / Q000532:radiotherapy; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007680:Kidney Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism / Q000532:radiotherapy; D008545:Melanoma / Q000378:metabolism / Q000532:radiotherapy / Q000556:secondary; D013238:Stereotaxic Techniques; D014055:Tomography, Emission-Computed
D005462:Fluorine Radioisotopes; D019788:Fluorodeoxyglucose F18; D003847:Deoxyglucose; D005947:Glucose